title: Ultraviolet recall phenomenon associated with methotrexate and cytarabine.
authors.forename: T I
authors.initials: TI
authors.lastname: Kaya
authors.forename: N
authors.initials: N
authors.lastname: Tiftik
authors.forename: U
authors.initials: U
authors.lastname: Tursen
authors.forename: G
authors.initials: G
authors.lastname: Ikizoglu
authors.forename: A
authors.initials: A
authors.lastname: Yalcin
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001132:Arm; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D014466:Ultraviolet Rays / Q000009:adverse effects
chemical_list: D003561:Cytarabine; D008727:Methotrexate